Provided by Tiger Trade Technology Pte. Ltd.

Exagen

7.58
+0.04000.53%
Post-market: 7.730.1500+1.98%19:30 EDT
Volume:138.17K
Turnover:1.04M
Market Cap:183.63M
PE:-9.47
High:7.62
Open:7.40
Low:7.38
Close:7.54
52wk High:12.23
52wk Low:2.59
Shares:24.23M
Float Shares:13.99M
Volume Ratio:0.52
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8001
EPS(LYR):-0.9300
ROE:-113.82%
ROA:-14.92%
PB:15.03
PE(LYR):-8.15

Loading ...

Exagen beats Q1 revenue estimates, reaffirms 2026 guidance

Reuters
·
May 11

Exagen Q1 FY26 net loss widens to $3.97 million; revenue rises 12% to $17.3 million

Reuters
·
May 11

Exagen Q1 EPS $(0.17) Beats $(0.23) Estimate, Sales $17.306M Beat $16.414M Estimate

Benzinga Earnings
·
May 11

Exagen Inc - Maintains FY2026 Revenue Guidance of $70 Mln to $73 Mln

THOMSON REUTERS
·
May 11

Exagen Inc. Q1 Operating Expenses USD 13.619 Million

THOMSON REUTERS
·
May 11

Exagen Inc. Q1 Revenue USD 17.306 Million VS. Ibes Estimate USD 16.4 Million

THOMSON REUTERS
·
May 11

Exagen Inc. Reports First Quarter 2026 Results

GlobeNewswire
·
May 11

Exagen Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
May 08

Exagen announces annual shareholder meeting

Reuters
·
Apr 28

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

GlobeNewswire
·
Apr 27

Exagen Announces Board Resignation and Committee Restructuring

TIPRANKS
·
Apr 24

Exagen director Ana Hooker resigns from board, committees effective immediately

Reuters
·
Apr 24

Envoy Medical names Charles McKhann to board, Compensation Committee

Reuters
·
Apr 22

Exagen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 21

Exagen price target lowered to $8 from $10 at Canaccord

TIPRANKS
·
Apr 20

Exagen Inc. files initial beneficial ownership statement for director Chas McKhann

Reuters
·
Mar 17

B. Riley Securities Keeps Their Buy Rating on Exagen (XGN)

TIPRANKS
·
Mar 12

Exagen price target lowered to $10 from $12 at Craig-Hallum

TIPRANKS
·
Mar 11

Exagen (XGN) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Mar 11

Exagen price target lowered to $10 from $15 at KeyBanc

TIPRANKS
·
Mar 11